Carcinoma del timo

1. D. Blumberg, J.L. Port, B. Weksler et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg, 60 (1995), pp. 908–914
2. Y.L. Tseng, S.T. Wang, M.H. Wu, M.Y. Lin, W.W. Lai, F.F. Cheng. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg, 76 (2003), pp. 1041–1045.
3. K. Kondo, Y. Monden. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg, 76 (2003), pp. 878–885.
4. D.C. Snover, G.D. Levine, J. Rosai. Thymic carcinomaFive distinctive histological variants. Am J Surg Pathol, 6 (1982), pp. 451–470.
5. G.D. Levine, J. Rosai. Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol, 9 (1978), pp. 495–515.
6. N.P. Bergh, P. Gatzinsky, S. Larsson, P. Lundin, B. Ridell. Tumors of the thymus and thymic region: IClinicopathological studies on thymomas. Ann Thorac Surg, 25 (1978), pp. 91–98.
7. H.C. Liu, W.H. Hsu, Y.J. Chen et al. Primary thymic carcinoma. Ann Thorac Surg, 73 (2002), pp. 1076–1081.
8. R. Maruyama, R. Suemitsu, T. Okamoto et al. Persistent and aggressive treatment for thymic carcinomaResults of a single-institute experience with 25 patients. Oncology, 70 (2006), pp. 325–329.
9. S. Suster, J. Rosai. Thymic carcinomaA clinicopathologic study of 60 cases. Cancer, 67 (1991), pp. 1025–1032.
10. M. Yano, H. Sasaki, T. Yokoyama et al. Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol, 3 (2008), pp. 265–269.
11. Y. Hosaka, M. Tsuchida, S. Toyabe, H. Umezu, T. Eimoto, J. Hayashi. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg, 89 (2010), pp. 912–917.
12. K. Ogawa, T. Toita, T. Uno et al. Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases. Cancer, 94 (2002), pp. 3115–3119.
13. F. Venuta, M. Anile, D. Diso et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg, 37 (2010), pp. 13–25.
14. D.A. Chung. Thymic carcinoma—analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg, 48 (2000), pp. 114–119.
15. M. Okumura, M. Ohta, S. Miyoshi et al. Oncological significance of WHO histological thymoma classificationA clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg, 50 (2002), pp. 189–194.
16. K. Kondo. Tumor-node metastasis staging system for thymic epithelial tumors. J Thorac Oncol, 5 (10 Suppl 4) (2010), pp. S352–S356.
17. F.C. Detterbeck. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg, 81 (2006), pp. 2328–2334.
18. T. Yano, N. Hara, Y. Ichinose, H. Asoh, H. Yokoyama, M. Ohta. Treatment and prognosis of primary thymic carcinoma. J Surg Oncol, 52 (1993), pp. 255–258.
19. L.G. Weide, T.M. Ulbright, P.J. Loehrer Sr, S.D. Williams. Thymic carcinoma A distinct clinical entity responsive to chemotherapy. Cancer, 71 (1993), pp. 1219–1223.
20. R.W. Carlson, R.F. Dorfman, B.I. Sikic. Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy. Cancer, 66 (1990), pp. 2092–2094.
21. A. Masaoka. Staging system of thymoma. J Thorac Oncol, 5 (10 Suppl 4) (2010), pp. S304–S312.
22. T. Onuki, S. Ishikawa, T. Yamamoto et al. Pathologic radioresponse of preoperatively irradiated invasive thymomas. J Thorac Oncol, 3 (2008), pp. 270–276